Cancer of the Prostate Clinical Trials in Montreal, Quebec
2 recruitingMontreal, Quebec, Canada
Showing 1–2 of 2 trials
Recruiting
Phase 3
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled295 locationsNCT07028853
Recruiting
Not Applicable
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
AnxietyCancer of the Prostate
St. Mary's Research Center, Canada376 enrolled2 locationsNCT06363266